As you know, we look for stocks that have a high probability of making big price gains and Tuesdays alert didn’t disappoint. It was up 72% at its high!
It closed up 48% and moved at a solid pace throughout the day giving traders ample opportunities at profit taking.
Congratulations if you were able to book profits Tuesday!
Okay, on to the next one.
Our alert for Thursday has both a positive balance sheet and a great story so we think investors are going to really get excited about this one.
Thursday’s alert is Immunotech Laboratories, Inc.,
The symbol is IMMB and the stock closed Wednesday at 21 cents.
IMMB is a drug development company focused on immuno-therapeutic treatment and prevention of HIV/AIDS, Cancer and other immuno related disorders.
IMMB’s flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective treatment for HIV/Aids.
Right now HIV stocks are SIZZLING, after news on Monday that a baby born with the virus has been cured!This has made the whole sector HOT.
Here’s why we particularly like IMMB:
IMMB just announced a $2M funding approval from Bulgarian Immunotech Partnership Company (Immunotech BG) to begin clinical trials for their ITV drug.
IMMB has negotiated with two of the largest Bulgarian Hospitals for the start of Clinical Trials on a total of 100 advanced stage patients.
The clinical trials in Bulgaria are scheduled to begin THIS MONTH and end in August 2013
This is HUGE!
IMMB is getting the word out about their company through celebrity endorsers; Sugar Ray Leonard, Thomas “The Hit Man” Hearns, and Corey Feldman.
IMMB has also started restructuring, and has added new board members with a goal of up-listing to NASDAQ.
This is all very exciting stuff.
Drug development companies often require capital to get through the testing phases, and if successful, reward their investors 10 fold when the drug obtains approval.
That’s why the fact they have more assets than liabilities ($10 mm vs. $3 mm) is important.
Also why it’s smart to have celebrity endorsers and a goal of reaching Nasdaq listing, which should help lure higher Net Worth investors.
For our purposes this story is excellent. People will latch on to a company like this. Some will want to bet the farm and tell everyone they know about it.
We don’t bet the farm though, we play the stock. As investors and traders learn about this, Thursday will be an active day for the stock and should give savvy traders some exciting trade opportunities.
IMMB can move, the last time the stock was very active it went from 6 cents to 45 cents in early February. That’s a 650% run!
Since the stock hasn’t received much attention profit takers brought the stock down to its current price.
When IMMB begins to get active Thursday, it could begin to aim for new highs.
Be sure IMMB is the first stock you look at Thursday morning.
As always, do your own research, don’t chase gaps, use limit ordersto enter positions, always use stop loss orders to protect yourposition, and take profits when you are in a position to do so.